19
Aug
DPHARMA - Notice of Book Closure
18
Aug
OTHERS
Duopharma Biotech maintains healthy profit growth in H1FY2026
18
Aug
First Interim Dividend
18
Aug
Quarterly rpt on consolidated results for the financial period ended 30/06/2026
11
Aug
MATERIAL LITIGATION
KUALA LUMPUR HIGH COURT CIVIL SUIT NO. WA-22IP-15-02/2025 - WRIT OF SUMMONS AND STATEMENT OF CLAIM SERVED ON DUOPHARMA MANUFACTURING (BANGI) SDN. BHD. (A WHOLLY-OWNED SUBSIDIARY OF DUOPHARMA BIOTECH BERHAD) BY SUN PHARMACEUTICAL INDUSTRIES LIMITED
07
Aug
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
31
Jul
OTHERS
CONTRACTS FOR THE SUPPLY BY DUOPHARMA (M) SENDIRIAN BERHAD, DUOPHARMA MANUFACTURING (BANGI) SDN. BHD. AND DUOPHARMA HAPI SDN. BHD. (ALL WHOLLY-OWNED SUBSIDIARY COMPANIES OF DUOPHARMA BIOTECH BERHAD), THROUGH PHARMANIAGA LOGISTICS SDN. BHD. OF PHARMACEUTICAL AND/OR NON-PHARMACEUTICAL PRODUCTS FOR THE MINISTRY OF HEALTH OF MALAYSIA UNDER THE APPROVED PRODUCTS PURCHASE LIST
(Announcement pursuant to Chapter 9 of Bursa Malaysia Securities Berhad Main Market Listing Requirements)
28
Jul
MATERIAL LITIGATION
KUALA LUMPUR HIGH COURT CIVIL SUIT NO. WA-22IP-15-02/2025 - WRIT OF SUMMONS AND STATEMENT OF CLAIM SERVED ON DUOPHARMA MANUFACTURING (BANGI) SDN. BHD. (A WHOLLY-OWNED SUBSIDIARY OF DUOPHARMA BIOTECH BERHAD) BY SUN PHARMACEUTICAL INDUSTRIES LIMITED
20
Jul
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
09
Jul
MATERIAL LITIGATION
KUALA LUMPUR HIGH COURT CIVIL SUIT NO. WA-22IP-15-02/2025 - WRIT OF SUMMONS AND STATEMENT OF CLAIM SERVED ON DUOPHARMA MANUFACTURING (BANGI) SDN. BHD. (A WHOLLY-OWNED SUBSIDIARY OF DUOPHARMA BIOTECH BERHAD) BY SUN PHARMACEUTICAL INDUSTRIES LIMITED
09
Jun
MATERIAL LITIGATION
MATERIAL LITIGATION KUALA LUMPUR HIGH COURT CIVIL SUIT NO. WA-22IP-15-02/2025 - WRIT OF SUMMONS AND STATEMENT OF CLAIM SERVED ON DUOPHARMA MANUFACTURING (BANGI) SDN. BHD. (A WHOLLY-OWNED SUBSIDIARY OF DUOPHARMA BIOTECH BERHAD) BY SUN PHARMACEUTICAL INDUSTRIES LIMITED
09
Jun
OTHERS
ACCEPTANCE OF TENDER OFFER (HEREINAFTER REFERRED TO AS THE "LETTER OF AWARD" OR "LOA") FOR THE SUPPLY OF RECOMBINANT HUMAN INSULIN 100 IU/ML PENFILL/REFILL AS A PACKAGE (HEREINAFTER REFERRED TO AS THE "PRODUCTS") BY DUOPHARMA (M) SENDIRIAN BERHAD (A WHOLLY-OWNED SUBSIDIARY OF DUOPHARMA BIOTECH BERHAD) TO THE MINISTRY OF HEALTH'S FACILITIES FOR THREE YEARS
(Announcement pursuant to Chapter 9 of Bursa Malaysia Securities Berhad Main Market Listing Requirements)
22
May
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
21
May
OTHERS
Duopharma Biotech Contributes to National Pharmaceutical Self-Reliance Through Manufacturing Capacity and Portfolio Growth
21
May
General Meetings: Outcome of Meeting
20
May
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
14
May
OTHERS
Duopharma Biotech sees profit growth in Q1FY2026 alongside insulin supply normalisation
14
May
Quarterly rpt on consolidated results for the financial period ended 31/03/2026
04
May
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - YAYASAN PELABURAN BUMIPUTRA
04
May
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - PERMODALAN NASIONAL BERHAD
21
Apr
Annual Audited Accounts - 31 Dec 2025
21
Apr
Annual Report & CG Report - 2025
20
Apr
General Meetings: Notice of Meeting
31
Mar
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
24
Mar
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
19
Mar
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
10
Mar
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
09
Mar
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
06
Mar
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
05
Mar
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD